Search Results 331-340 of 18470 for Relapse

  1. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

    T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer · More about research at Mayo Clinic.

  2. Medical Research & Education - Mayo Clinic News Network

    Science Saturday: Genetic test solves mystery of family bleeding disorder featured image · Study shows drug reduces risk of relapse with neuromyelitis optica ...

  3. A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas - Mayo Clinic

    The purpose of this study is to evaluate CC-220 alone, as well as in combination with an anti-CD20 mAb (rituximab or obinutuzumab) in subjects with relapsed or ...

  4. Leukemia Clinical Trials - Mayo Clinic Research

    The secondary objectives include; evaluation of morphologic relapse free survival (RFS), evaluation of overall survival (OS), assessment of the the survival ...

  5. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

    ... relapse with positive ocular tissue biopsy. NOTE: tissue biopsy is not ... Relapsed/refractory primary vitreoretinal diffuse large B cell lymphoma (DLBCL) with a ...

  6. Medical Research & Education - Mayo Clinic News Network

    Is the definition of Alzheimer's disease changing? · Mayo researchers correlate specific antibody with relapse of neurological disorder featured image · COPD / ...

  7. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    The study is designed to determine if JCAR017 is superior to current standard of care (SOC) therapy for the treatment of relapsed/refractory aggressive non- ...

  8. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI. Joe Dangor. October 5, 2016. Discovery's Edge: Beat still my beating ...

  9. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI featured. Cancer. Mayo Clinic researchers map prostate cancer relapse using C ...

  10. Hematology - Clinical trials

    The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed ... Patients at high risk of relapse are ...